Hyperferritinemia after adult allogeneic hematopoietic cell transplantation: Quantification of iron burden by determining non-transferrin-bound iron

International Journal of Hematology

Volumn 97, Issue 1, 2013, Pages 125-134

  Goto, Tatsunori ^a   Ikuta, Katsuya ^b   Inamoto, Yoshihiro ^a   Kamoshita, Sonoko ^a   Yokohata, Emi ^a   Koyama, Daisuke ^a   Onodera, Koichi ^a   Seto, Aika ^a   Watanabe, Keisuke ^a   Imahashi, Nobuhiko ^a   Tsukamoto, Shokichi ^a   Ozawa, Yukiyasu ^a   Sasaki, Katsunori ^b   Ito, Masafumi ^a   Kohgo, Yutaka ^b   Miyamura, Koichi ^a  

^a JAPANESE RED CROSS NAGOYA FIRST HOSPITAL   (Japan)

^b ASAHIKAWA MEDICAL COLLEGE   (Japan)

Author keywords

Ferritin; Hematopoietic cell transplantation; Hyperferritinemia; Iron overload; Non transferrin bound iron

Indexed keywords

FERRITIN; IRON; NON TRANSFERRIN BOUND IRON; UNCLASSIFIED DRUG;

ADOLESCENT; ADULT; AGED; ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION; ARTICLE; CORRELATION ANALYSIS; DIABETES MELLITUS; ERYTHROCYTE COUNT; FEMALE; FERRITIN BLOOD LEVEL; HUMAN; HYPERFERRITINEMIA; IRON BLOOD LEVEL; IRON OVERLOAD; LIVER DYSFUNCTION; MAJOR CLINICAL STUDY; MALE; QUANTITATIVE ANALYSIS;

ADOLESCENT; ADULT; AGED; FEMALE; FERRITINS; HEMATOLOGIC DISEASES; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMANS; IRON; IRON OVERLOAD; LIVER; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; TRANSPLANTATION, HOMOLOGOUS; TREATMENT OUTCOME; YOUNG ADULT;

EID: 84872932126     PISSN: 09255710     EISSN: 18653774     Source Type: Journal    
DOI: 10.1007/s12185-012-1252-1     Document Type: Article

References (35)

1. Rizzo JD, Wingard JR, Tichelli A, Lee SJ, Van Lint MT, Burns LJ, et al. Recommended screening and preventive practices for long-term survivors after hematopoietic cell transplantation: joint recommendations of the European Group for Blood and Marrow Transplantation, the Center for International Blood and Marrow Transplant Research, and the American Society of Blood and Marrow Transplantation. Biol Blood Marrow Transpl. 2006;12:138-51. (Pubitemid 43138009)
2. Busca A, Falda M, Manzini P, D'Antico S, Valfre A, Locatelli F, et al. Iron overload in patients receiving allogeneic hematopoietic stem cell transplantation: quantification of iron burden by a superconducting quantum interference device (SQUID) and therapeutic effectiveness of phlebotomy. Biol Blood Marrow Transpl. 2010;16:115-22.
3. Majhail NS, DeFor T, Lazarus HM, Burns LJ. High prevalence of iron overload in adult allogeneic hematopoietic cell transplant survivors. Biol Blood Marrow Transpl. 2008;14:790-4. (Pubitemid 351773155)
4. Kamble RT, Selby GB, Mims M, Kharfan-Dabaja MA, Ozer H, George JN. Iron overload manifesting as apparent exacerbation of hepatic graft-versus-host disease after allogeneic hematopoietic stem cell transplantation. Biol Blood Marrow Transpl. 2006;12:506-10. (Pubitemid 43964819)
5. Kontoyiannis DP, Chamilos G, Lewis RE, Giralt S, Cortes J, Raad II, et al. Increased bone marrow iron stores is an independent risk factor for invasive aspergillosis in patients with high-risk hematologic malignancies and recipients of allogeneic hematopoietic stem cell transplantation. Cancer. 2007;110:1303-6. (Pubitemid 47435602)
6. Gaziev D, Baronciani D, Galimberti M, Polchi P, Angelucci E, Giardini C, et al. Mucormycosis after bone marrow transplantation: report of four cases in thalassemia and review of the literature. Bone Marrow Transpl. 1996;17:409-14.
7. Gordon LI, Brown SG, Tallman MS, Rademaker AW, Weitzman SA, Lazarus HM, et al. Sequential changes in serum iron and ferritin in patients undergoing high-dose chemotherapy and radiation with autologous bone marrow transplantation: possible implications for treatment related toxicity. Free Radic Biol Med. 1995;18:383-9.
8. Evens AM, Mehta J, Gordon LI. Rust and corrosion in hematopoietic stem cell transplantation: the problem of iron and oxidative stress. Bone Marrow Transpl. 2004;34:561-71. (Pubitemid 39341534)
9. Majhail NS, Lazarus HM, Burns LJ. Iron overload in hematopoietic cell transplantation. Bone Marrow Transpl. 2008;41:997-1003. (Pubitemid 352034174)
10. Sasaki K, Ikuta K, Tanaka H, Ohtake T, Torimoto Y, Fujiya M, et al. Improved quantification for non-transferrin-bound iron measurement using high-performance liquid chromatography by reducing iron contamination. Mol Med Report. 2011;4:913-8.
11. Jakeman A, Thompson T, McHattie J, Lehotay DC. Sensitive method for nontransferrin-bound iron quantification by graphite furnace atomic absorption spectrometry. Clin Biochem. 2001;34:43-7. (Pubitemid 32178504)
12. Zhang D, Okada S, Kawabata T, Yasuda T. An improved simple colorimetric method for quantitation of non-transferrin-bound iron in serum. Biochem Mol Biol Int. 1995;35:635-41. (Pubitemid 26177837)
13. Gosriwatana I, Loreal O, Lu S, Brissot P, Porter J, Hider RC. Quantification of non-transferrin-bound iron in the presence of unsaturated transferrin. Anal Biochem. 1999;273:212-20. (Pubitemid 29430665)
14. Loreal O, Gosriwatana I, Guyader D, Porter J, Brissot P, Hider RC. Determination of non-transferrin-bound iron in genetic hemochromatosis using a new HPLC-based method. J Hepatol. 2000;32:727-33. (Pubitemid 30262731)
15. Gutteridge JM, Hou YY. Iron complexes and their reactivity in the bleomycin assay for radical-promoting loosely-bound iron. Free Radic Res Commun. 1986;2:143-51.
16. Breuer W, Ronson A, Slotki IN, Abramov A, Hershko C, Cabantchik ZI. The assessment of serum nontransferrin-bound iron in chelation therapy and iron supplementation. Blood. 2000;95:2975-82. (Pubitemid 30235912)
17. Breuer W, Ermers MJ, Pootrakul P, Abramov A, Hershko C, Cabantchik ZI. Desferrioxamine-chelatable iron, a component of serum non-transferrin-bound iron, used for assessing chelation therapy. Blood. 2001;97:792-8. (Pubitemid 32113415)
18. Breuer W, Cabantchik ZI. A fluorescence-based one-step assay for serum non-transferrin-bound iron. Anal Biochem. 2001;299:194-202. (Pubitemid 34053410)
19. McNamara L, MacPhail AP, Mandishona E, Bloom P, Paterson AC, Rouault TA, et al. Non-transferrin-bound iron and hepatic dysfunction in African dietary iron overload. J Gastroenterol Hepatol. 1999;14:126-32. (Pubitemid 29092869)
20. Esposito BP, Breuer W, Sirankapracha P, Pootrakul P, Hershko C, Cabantchik ZI. Labile plasma iron in iron overload: redox activity and susceptibility to chelation. Blood. 2003;102:2670-7. (Pubitemid 37193611)
21. al-Refaie FN, Wickens DG, Wonke B, Kontoghiorghes GJ, Hoffbrand AV. Serum non-transferrin-bound iron in beta-thalassaemia major patients treated with desferrioxamine and L1. Br J Haematol. 1992;82:431-6.
22. Cabantchik ZI, Breuer W, Zanninelli G, Cianciulli P. LPI-labile plasma iron in iron overload. Best Pract Res Clin Haematol. 2005;18:277-87. (Pubitemid 40298370)
23. Taher A, Musallam KM, El Rassi F, Duca L, Inati A, Koussa S, et al. Levels of non-transferrin-bound iron as an index of iron overload in patients with thalassaemia intermedia. Br J Haematol. 2009;146:569-72.
24. Jensen PD, Jensen FT, Christensen T, Nielsen JL, Ellegaard J. Relationship between hepatocellular injury and transfusional iron overload prior to and during iron chelation with desferrioxamine: A study in adult patients with acquired anemias. Blood. 2003;101:91-6. (Pubitemid 36025892)
25. Takatoku M, Uchiyama T, Okamoto S, Kanakura Y, Sawada K, Tomonaga M, et al. Retrospective nationwide survey of Japanese patients with transfusion-dependent MDS and aplastic anemia highlights the negative impact of iron overload on morbidity/mortality. Eur J Haematol. 2007;78:487-94. (Pubitemid 46753591)
26. Rose C, Ernst O, Hecquet B, Maboudou P, Renom P, Noel MP, et al. Quantification by magnetic resonance imaging and liver consequences of post-transfusional iron overload alone in long term survivors after allogeneic hematopoietic stem cell transplantation (HSCT). Haematologica. 2007;92:850-3. (Pubitemid 350155314)
27. Brittenham GM, Cohen AR, McLaren CE, Martin MB, Griffith PM, Nienhuis AW, et al. Hepatic iron stores and plasma ferritin concentration in patients with sickle cell anemia and thalassemia major. Am J Hematol. 1993;42:81-5. (Pubitemid 23008317)
28. Olivieri NF, Brittenham GM, Matsui D, Berkovitch M, Blendis LM, Cameron RG, et al. Iron-chelation therapy with oral deferipronein patients with thalassemia major. N Engl J Med. 1995;332:918-22.
29. Karam LB, Disco D, Jackson SM, Lewin D, McKie V, Baker RD, et al. Liver biopsy results in patients with sickle cell disease on chronic transfusions: poor correlation with ferritin levels. Pediatr Blood Cancer. 2008;50:62-5. (Pubitemid 350234267)
30. Sahlstedt L, Ebeling F, von Bonsdorff L, Parkkinen J, Ruutu T. Non-transferrin-bound iron during allogeneic stem cell transplantation. Br J Haematol. 2001;113:836-8. (Pubitemid 32524411)
31. Sahlstedt L, von Bonsdorff L, Ebeling F, Parkkinen J, Juvonen E, Ruutu T. Non-transferrin-bound iron in haematological patients during chemotherapy and conditioning for autologous stem cell transplantation. Eur J Haematol. 2009;83:455-9.
32. Pullarkat V, Blanchard S, Tegtmeier B, Dagis A, Patane K, Ito J, et al. Iron overload adversely affects outcome of allogeneic hematopoietic cell transplantation. Bone Marrow Transpl. 2008;42:799-805.
33. Sucak GT, Yegin ZA, Ozkurt ZN, Aki SZ, Karakan T, Akyol G. The role of liver biopsy in the workup of liver dysfunction late after SCT: is the role of iron overload underestimated? Bone Marrow Transpl. 2008;42:461-7.
34. Chatterjee R, Bajoria R. New concept in natural history and management of diabetes mellitus in thalassemia major. Hemoglobin. 2009;33(Suppl 1):S127-30.
35. Papanikolaou G, Pantopoulos K. Iron metabolism and toxicity. Toxicol Appl Pharmacol. 2005;202:199-211. (Pubitemid 40040559)